Literature DB >> 21656128

2-Methoxyestradiol-bis-sulfamate induces apoptosis and autophagy in a tumorigenic breast epithelial cell line.

M H Visagie1, A M Joubert.   

Abstract

In anticancer research where the focus is on finding agents that induces cell death while leaving non-tumorigenic cells less affected, a novel 2-methoxyestradiol derivative has come forth. 2-Methoxyestradiol-bis-sulfamate (2-MeOE2bisMATE) is a 2-methoxyestradiol derivative produced by bis-sulphamoylation, which possesses increased antiproliferative activity and biological availability. Several questions remain regarding the type of cell death mechanisms and possible induction of autophagy by 2-MeOE2bisMATE. The aim of this in vitro study was to investigate the cell death mechanisms exerted by 2-MeOE2bisMATE in an adenocarcinoma cell line (MCF-7) by analyzing its influence on cell growth, morphology, and possible induction of cell death. Spectrophotometry (crystal violet staining), transmission electron microscopy (TEM), light microscopy (hematoxylin and eosin staining), and fluorescent microscopy (Hoechst 33342, propidium iodide and acridine orange) were employed. Spectrophotometrical studies indicated that 2-MeOE2bisMATE decreased cell numbers to 75% in MCF-7 cells after 24 h and to 47% after 48 h of exposure. TEM demonstrated membrane blebbing, nuclear fragmentation, and chromatin condensation indicating the hallmarks of apoptosis. Light microscopy revealed the presence of several cells blocked in metaphase, and apoptotic cells were also observed. Fluorescent microscopy demonstrated increased lysosomal staining; suggesting the induction of autophagy. 2-MeOE2bisMATE shows therapeutic potential, as an, anticancer agent, and the investigation of the cell death mechanisms used by 2-MeOE2bisMATE, thus, warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21656128     DOI: 10.1007/s11010-011-0905-3

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  34 in total

Review 1.  Another way to die: autophagic programmed cell death.

Authors:  Y Tsujimoto; S Shimizu
Journal:  Cell Death Differ       Date:  2005-11       Impact factor: 15.828

Review 2.  2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate.

Authors:  V S Pribluda; E R Gubish; T M Lavallee; A Treston; G M Swartz; S J Green
Journal:  Cancer Metastasis Rev       Date:  2000       Impact factor: 9.264

3.  2-Methoxyestradiol blocks estrogen-induced rat pituitary tumor growth and tumor angiogenesis: possible role of vascular endothelial growth factor.

Authors:  S K Banerjeei; M N Zoubine; D K Sarkar; A P Weston; J H Shah; D R Campbell
Journal:  Anticancer Res       Date:  2000 Jul-Aug       Impact factor: 2.480

4.  Effect of 2-methoxyestradiol on the growth of methyl-nitroso-urea (MNU)-induced rat mammary carcinoma.

Authors:  T H Lippert; H Adlercreutz; M R Berger; H Seeger; W Elger; A O Mueck
Journal:  J Steroid Biochem Mol Biol       Date:  2003-01       Impact factor: 4.292

5.  Activity of 2 methoxyestradiol (Panzem NCD) in advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: a Hoosier Oncology Group trial.

Authors:  Daniela Matei; Jeanne Schilder; Gregory Sutton; Susan Perkins; Tim Breen; Check Quon; Carolyn Sidor
Journal:  Gynecol Oncol       Date:  2009-07-04       Impact factor: 5.482

6.  STX140 and STX641 cause apoptosis via the intrinsic mitochondrial pathway and down-regulate survivin and XIAP expression in ovarian and prostate cancer cells.

Authors:  Paul A Foster; Yaik T Ho; Simon P Newman; Mathew P Leese; Barry V L Potter; Michael J Reed; Atul Purohit
Journal:  Anticancer Res       Date:  2009-10       Impact factor: 2.480

Review 7.  The National Cancer Institute: cancer drug discovery and development program.

Authors:  M R Grever; S A Schepartz; B A Chabner
Journal:  Semin Oncol       Date:  1992-12       Impact factor: 4.929

8.  A new micronized formulation of 2-methoxyestradiol-bis-sulfamate (STX140) is therapeutically potent against breast cancer.

Authors:  Paul A Foster; Simon P Newman; Mathew P Leese; Sonia Bernetiere; Christian Diolez; Jose Camara; Beatrice Hacher; Marie-Madeleine Baronnet; Tauhid Ali; Barry V L Potter; Michael J Reed; Atul Purohit
Journal:  Anticancer Res       Date:  2008 Mar-Apr       Impact factor: 2.480

9.  Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells.

Authors:  T Kanzawa; I M Germano; T Komata; H Ito; Y Kondo; S Kondo
Journal:  Cell Death Differ       Date:  2004-04       Impact factor: 15.828

Review 10.  2-Methoxyestradiol--a unique blend of activities generating a new class of anti-tumour/anti-inflammatory agents.

Authors:  Tara E Sutherland; Robin L Anderson; Richard A Hughes; Emile Altmann; Michael Schuliga; James Ziogas; Alastair G Stewart
Journal:  Drug Discov Today       Date:  2007-06-26       Impact factor: 7.851

View more
  9 in total

1.  In vitro effects of 2-methoxyestradiol-bis-sulphamate on reactive oxygen species and possible apoptosis induction in a breast adenocarcinoma cell line.

Authors:  Michelle H Visagie; Anna M Joubert
Journal:  Cancer Cell Int       Date:  2011-12-12       Impact factor: 5.722

2.  A 2-methoxyestradiol bis-sulphamoylated derivative induces apoptosis in breast cell lines.

Authors:  Michelle Helen Visagie; Lyn-Marie Birkholtz; Anna Margaretha Joubert
Journal:  Cell Biosci       Date:  2015-04-22       Impact factor: 7.133

3.  Induction of the intrinsic apoptotic pathway via a new antimitotic agent in an esophageal carcinoma cell line.

Authors:  Elize Wolmarans; Katherine Sippel; Robert McKenna; Annie Joubert
Journal:  Cell Biosci       Date:  2014-11-20       Impact factor: 7.133

4.  AC-1001 H3 CDR peptide induces apoptosis and signs of autophagy in vitro and exhibits antimetastatic activity in a syngeneic melanoma model.

Authors:  Aline N Rabaça; Denise C Arruda; Carlos R Figueiredo; Mariana H Massaoka; Camyla F Farias; Dayane B Tada; Vera C Maia; Pedro I Silva Junior; Natalia Girola; Fernando Real; Renato A Mortara; Luciano Polonelli; Luiz R Travassos
Journal:  FEBS Open Bio       Date:  2016-07-15       Impact factor: 2.693

5.  In vitro assessment of a computer-designed potential anticancer agent in cervical cancer cells.

Authors:  Michelle Helen Visagie; Seema Rummurat Jaiswal; Anna Margaretha Joubert
Journal:  Biol Res       Date:  2016-11-02       Impact factor: 5.612

6.  A novel non-sulphamoylated 2-methoxyestradiol derivative causes detachment of breast cancer cells by rapid disassembly of focal adhesions.

Authors:  Mandie Botes; Tamarin Jurgens; Anna Margaretha Joubert; Iman van den Bout; Zohreh Riahi; Michelle Visagie; Rustelle Janse van Vuuren
Journal:  Cancer Cell Int       Date:  2018-11-19       Impact factor: 5.722

7.  Modes of cell death induced by tetrahydroisoquinoline-based analogs in MDA-MB-231 breast and A549 lung cancer cell lines.

Authors:  Marcel Nel; Anna M Joubert; Wolfgang Dohle; Barry Vl Potter; Anne E Theron
Journal:  Drug Des Devel Ther       Date:  2018-06-25       Impact factor: 4.162

8.  2-Methoxyestradiol-bis-sulphamate refrains from inducing apoptosis and autophagy in a non-tumorigenic breast cell line.

Authors:  Michelle H Visagie; Anna M Joubert
Journal:  Cancer Cell Int       Date:  2012-08-20       Impact factor: 5.722

9.  An estrogen analogue and promising anticancer agent refrains from inducing morphological damage and reactive oxygen species generation in erythrocytes, fibrin and platelets: a pilot study.

Authors:  Lisa Repsold; Etheresia Pretorius; Annie Margaretha Joubert
Journal:  Cancer Cell Int       Date:  2014-06-07       Impact factor: 5.722

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.